News

InnovAge Earns Recognition as a Top Workplace in Aging Services

InnovAge Earns Recognition as a Top Workplace in Aging Services

InnovAge Recognized as Top Workplace for Aging Services

InnovAge (NASDAQ: INNV), a prominent provider in the Program of All-Inclusive Care for the Elderly (PACE), has achieved significant recognition by being named one of the best workplaces in aging services. With a ranking among the top 15 organizations nationwide, this accolade highlights InnovAge’s dedication to fostering an environment where employees thrive and feel valued.

Commitment to Quality and Supportive Culture

This achievement underscores the company’s commitment to high-quality, compassionate care for older adults. InnovAge employs over 2,400 individuals across various regions, ensuring that participants of its PACE program receive personal medical and social support around the clock. Thanks to the tireless efforts of its team, InnovAge plays a vital role in helping thousands of seniors live independently and safely in their homes.

Voices of Leadership

Patrick Blair, the CEO of InnovAge, expressed gratitude for this esteemed recognition. He stated, “Being recognized as one of the top workplaces in the country within the aging services industry is an extraordinary honor. Our employees are the heart of InnovAge. Their dedication to caring for seniors with dignity and respect, while also supporting one another, is what makes this recognition possible.”

Blair further emphasized the importance of the team’s mission, saying, “Our team members don’t just have jobs—they have a mission. We are proud to be recognized as one of the best places to work in aging services and even prouder of the extraordinary people who made this possible.”

Understanding the Award Criteria

The criteria for the Fortune Best Workplaces in Aging Services list involve a comprehensive analysis of confidential feedback from employees, various workplace programs, and the overarching organizational culture. Being ranked in the top 15 shows InnovAge's commitment not just to delivering extensive care for older adults, but also to nurturing a workplace where employees can excel.

Previous Accolades and Achievements

Furthermore, InnovAge was recognized earlier this year as a Great Place to Work®, marking the sixth time they have received this commendation. This repeated recognition highlights InnovAge's ongoing dedication to nurturing its workforce and mission.

A Closer Look at InnovAge and Its Services

InnovAge stands as a leader in managing the care of high-cost, frail seniors, particularly those who are dual-eligible. Their mission revolves around ensuring that older adults can age independently in their homes for as long as is safely possible. With a focus on improving care quality while reducing reliance on costly healthcare settings, InnovAge’s PACE model seeks to create a win-win scenario for all stakeholders involved—participants, their families, providers, and government payors alike.

As of mid-2025, InnovAge proudly serves about 7,740 participants across 20 centers in six states, reinforcing their essential role in the community.

Contacting InnovAge

For those interested in learning more about InnovAge’s services or workplace environment, media contacts are available. Lara Hazenfield serves as the Public Relations & Content Creation Manager, reachable at lhazenfield@innovage.com. Additionally, John Eddy from Goldin Solutions for InnovAge can be contacted at john@innovage.com.

Frequently Asked Questions

What is InnovAge and what services do they offer?

InnovAge is a leading provider of the Program of All-Inclusive Care for the Elderly (PACE), helping seniors receive personalized care while living independently.

How many employees does InnovAge have?

InnovAge employs over 2,400 team members across multiple states, contributing to its ability to offer extensive support to its participants.

What recent recognition has InnovAge received?

InnovAge was recently named one of the top 15 organizations in the Fortune Best Workplaces in Aging Services, along with being recognized as a Great Place to Work® for the sixth time.

What is the mission of InnovAge?

InnovAge’s mission is to enable older adults to age independently in their own homes safely, through a supportive care model.

How can I contact InnovAge for more information?

You can contact InnovAge's Public Relations Manager, Lara Hazenfield, at lhazenfield@innovage.com.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Valmet Expands Board Maker Deal in Asia With New Line

Updated Category News Views 87

If there's one thing Valmet understands, it's the beauty of a longstanding business relationship. On November 9, 2026, the Finnish powerhouse announced another feather in its cap—a new board making line order from a major client in Asia. This deal ain't just another tick in the order books. No, sir, it's about prowess and power in the paper game. Building on Existing...

Continue Reading
O-I Glass Faces Class Action: Investor Implications

Updated Category News Views 68

O-I Glass in Hot Water Over Misleading Statements I'll tell you, nothing gets my goat quite like uncovering deceptive practices in the corporate world. It seems O-I Glass, Inc. (NYSE: OI), might have played a fast one with its shareholders. The company is staring down the barrel of a class action lawsuit from Schall, Brown & Schwartz LLP, alleging they weren't entirely...

Continue Reading
KT&G Launches Heated Tobacco in Kazakhstan's Market

Updated Category News Views 43

KT&G Lights Up Kazakhstan In a bold move, KT&G is laying down the gauntlet in Kazakhstan's tobacco market, introducing its cutting-edge heated tobacco gizmo and a handful of sleek FAIIM sticks. Launching this October, these aren't just any devices—they're the FLEX locals have been waiting for, rebranded from South Korea's lil AIBLE and AIIM but made to fit right in with...

Continue Reading
Xiaomi's Smart Auto Factory Draws Global Media Praise

Updated Category News Views 178

Xiaomi Impresses Global Media in Beijing Factory Tour In the ever-changing world of NEVs (New Energy Vehicles), a tour of Xiaomi's smart auto factory in Beijing has made waves among global media folks. These scribes got an up-close look at Xiaomi's magic mix of tech and style on November 6, part of a grand media gathering. What's Under the Hood? Marcos Costa de Oliveira,...

Continue Reading
Intelligent Communication Forum Eyes Global Ecosystem Shift

Updated Category News Views 730

China's Grand Vision for Intelligent Communication You know what they say about big ideas—they start in the most bustling of places. And here we are in Wuxi, a city's pulse pounding with ambition, hosting the 2026 China International Intelligent Communication Forum. Picture it: From November 8th to 10th, movers, shakers, and visionaries are scribbling new blueprints for...

Continue Reading
Webull Faces Class Action Suit: Key Deadlines Loom

Updated Category News Views 323

The Clock is Ticking for Webull Investors If anyone's got a Webull stake, listen up! You’ve got a deadline that's staring you in the face: December 7, 2026. This is when you need to throw your hat in the ring to be a lead plaintiff in the Webull Corporation class action. We're talking securities fraud, folks, with allegations flying that would make your head spin....

Continue Reading
LG's ASIL D Certification: A Game Changer in Autos

Updated Category News Views 226

Why LG's ASIL D Certification Matters There ain't much in the tangled mess of automotive innovations these days that'll make a seasoned investor raise an eyebrow, but here comes LG Electronics grabbing the ASIL D certification like it's a badge of market honor. The ISO 26262 ASIL D is no walk in the park, folks—it's the top rung on the safety ladder, something that's...

Continue Reading
Niagara Networks Boosts TLS 1.3 Decryption to 90+ Gbps

Updated Category News Views 73

In a digital era where encryption is racing ahead like a runaway train, Niagara Networks has stepped up with some serious muscle enhancements to their ePacketron platform. They're not just playing catch-up with the latest TLS 1.3 decryption capabilities; they're leading the charge with a robust over 90 Gbps performance—no small feat in today's encrypted traffic...

Continue Reading
Novo's Semaglutide Shows Promise in MASH Study

Updated Category News Views 490

Semaglutide, a name on the lips of many investors looking for breakthroughs, is making waves again. This time, the stir comes from recent findings in the MASH field, and it's got folks in white coats quite excited. Revolutionary Results from Novo Novo Nordisk has announced promising results from their phase 3 ESSENCE trial that looks into semaglutide's effects on a...

Continue Reading
Innovent's SINTBILO® Hits Primary Endpoint in Study

Updated Category News Views 228

Innovent's Latest Breakthrough with SINTBILO® One moment you're sipping coffee, the next you're staring at a clinical milestone. Innovent Biologics has shouted from the rooftops that their drug, SINTBILO® (tafolecimab injection), has wrapped up its Phase 3 CREDIT-5 study, snagging the primary endpoint with both hands. This isn't just any drug; it's marked as the first...

Continue Reading
aria-label="Continue reading: JNJ's Dual-Antigen Therapy Shows Promise in Prostate Cancer"> Continue Reading